Newegg Commerce Inc vs Tenet Healthcare Corporation — how do they compare? Newegg Commerce Inc trades at $11.51 (market cap $243.30M), while Tenet Healthcare Corporation trades at $260 (market cap $20.98B). The key difference: Tenet Healthcare Corporation is far larger — about 86.2× Newegg Commerce Inc's market cap, and Tenet Healthcare Corporation is trading nearer its 52-week high, Newegg Commerce Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Newegg Commerce Inc for 14 Days and Tenet Healthcare Corporation for 15 Days on average.
| NEGG | THC | |
|---|---|---|
Market Cap | $243.30M | $20.98B |
Volume | 41,252 | 428,008 |
Sector | Consumer Cyclical | Health |
52-Week High | $92.74 | $280.77 |
52-Week Low | $11.49 | $161.37 |
Typical Hold Time | 14 Days | 15 Days |
Enterprise Value | $213.53M | $32.06B |
Signals from Pluang's Aura AI — not financial advice
NEGG trades at $12.01, up 0.84% today. The stock faces a bearish technical signal with moving averages indicating selling pressure, though oscillators are neutral. Fundamentally, revenue was $1.44 billion in 2025 with a net loss of $4.88 million, but recent quarters show earnings beats. The company is expanding partnerships, such as with Western Digital for AI storage solutions (Business Wire, 2026-09-24).
The outlook is mixed. Positive earnings momentum and strategic partnerships offer growth potential, but negative operating cash flow, high debt-to-asset ratios, and insider selling pose risks. Analyst consensus is a buy with a $7.75 price target, below the current price, suggesting caution. Investors should weigh improving profitability against liquidity concerns and market volatility.
Tenet Healthcare (THC) trades at $259.83, up 0.53% with a bullish technical signal. The stock shows strong fundamentals with consistent earnings beats (Q4 2025-Q2 2026) and robust profitability (ROE 53.31%, net margin 9.9%). Recent news highlights strong cash flow supporting capital returns and upcoming Q3 2026 results on October 29. Valuation appears reasonable with P/E of 10.07 and EV/EBITDA of 5.75.
THC presents a compelling investment case with strong analyst support (81% buy ratings) and 7% upside to consensus target of $283.36. Key catalysts include sustained earnings momentum and efficient capital allocation. Risks include surgical volume pressures and cash flow sustainability concerns amid aggressive buybacks. The stock's current technical setup near pivot point $259 suggests balanced risk-reward.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Newegg Commerce Inc is an e-commerce company offering direct sales and an online marketplace platform for IT computer components, consumer electronics, entertainment, smart home and gaming products and provides certain third-party logistics services globally.
Read more on NEGG →Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →